↓ Skip to main content

Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome

Overview of attention for article published in Frontiers in Pharmacology, April 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
3 news outlets
twitter
4 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome
Published in
Frontiers in Pharmacology, April 2020
DOI 10.3389/fphar.2020.00429
Pubmed ID
Authors

Francisco Díaz-Castro, Matías Monsalves-Álvarez, Leonel E. Rojo, Andrea del Campo, Rodrigo Troncoso

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 19%
Other 2 6%
Student > Bachelor 2 6%
Professor 2 6%
Student > Master 2 6%
Other 4 13%
Unknown 14 44%
Readers by discipline Count As %
Medicine and Dentistry 5 16%
Biochemistry, Genetics and Molecular Biology 4 13%
Neuroscience 3 9%
Agricultural and Biological Sciences 2 6%
Computer Science 1 3%
Other 2 6%
Unknown 15 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2024.
All research outputs
#1,520,297
of 25,931,626 outputs
Outputs from Frontiers in Pharmacology
#584
of 20,054 outputs
Outputs of similar age
#41,116
of 407,994 outputs
Outputs of similar age from Frontiers in Pharmacology
#20
of 499 outputs
Altmetric has tracked 25,931,626 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,054 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 407,994 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 499 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.